Global Pharmaceuticals & Biotech Most Popular Stocks

Eli Lilly

Market Cap: US$1.0t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$615.4b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

AbbVie

Market Cap: US$447.5b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Roche Holding

Market Cap: CHF 278.7b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Merck

Market Cap: US$314.8b

Operates as a healthcare company worldwide.

Novartis

Market Cap: CHF 242.6b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

AstraZeneca

Market Cap: UK£196.8b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Novo Nordisk

Market Cap: DKK 1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Amgen

Market Cap: US$200.5b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Thermo Fisher Scientific

Market Cap: US$195.6b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.

Gilead Sciences

Market Cap: US$161.8b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Pfizer

Market Cap: US$141.5b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Danaher

Market Cap: US$125.9b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Bristol-Myers Squibb

Market Cap: US$124.1b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Vertex Pharmaceuticals

Market Cap: US$119.9b

Operates as a biotechnology company in the United States, Europe, and internationally.

Sanofi

Market Cap: €91.8b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

GSK

Market Cap: UK£75.9b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Chugai Pharmaceutical

Market Cap: JP¥12.2t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Merck KGaA

Market Cap: €60.5b

Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.

Regeneron Pharmaceuticals

Market Cap: US$66.3b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

argenx

Market Cap: €49.8b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Takeda Pharmaceutical

Market Cap: JP¥9.0t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.

WuXi AppTec

Market Cap: CN¥372.4b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

UCB

Market Cap: €46.3b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥352.7b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

Bayer

Market Cap: €45.4b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Galderma Group

Market Cap: CHF 39.7b

Operates as a dermatology company worldwide.

Sun Pharmaceutical Industries

Market Cap: ₹4.7t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

Samsung BiologicsLtd

Market Cap: ₩70.3t

Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

Lonza Group

Market Cap: CHF 37.9b

Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

Haleon

Market Cap: UK£31.9b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Revolution Medicines

Market Cap: US$38.9b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

CSL

Market Cap: AU$54.7b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Natera

Market Cap: US$37.8b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Agilent Technologies

Market Cap: US$37.7b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Waters

Market Cap: US$36.4b

Provides analytical workflow solutions in Asia, the Americas, and Europe.